Barclays PLC Buys 153,576 Shares of Select Medical Holdings Co. (NYSE:SEM)

Barclays PLC raised its stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) by 396.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 192,357 shares of the health services provider's stock after purchasing an additional 153,576 shares during the quarter. Barclays PLC owned approximately 0.15% of Select Medical worth $6,707,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of SEM. XTX Topco Ltd purchased a new stake in Select Medical in the third quarter worth about $580,000. Jane Street Group LLC boosted its position in shares of Select Medical by 14.2% during the third quarter. Jane Street Group LLC now owns 127,504 shares of the health services provider's stock valued at $4,446,000 after purchasing an additional 15,827 shares in the last quarter. Quarry LP purchased a new stake in Select Medical in the third quarter worth $30,000. Point72 Asset Management L.P. raised its holdings in Select Medical by 144.2% in the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider's stock worth $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its position in Select Medical by 14.7% during the third quarter. Janus Henderson Group PLC now owns 54,021 shares of the health services provider's stock valued at $1,883,000 after buying an additional 6,922 shares during the period. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Stock Down 0.1 %

SEM stock traded down $0.02 during trading on Thursday, hitting $18.26. 849,212 shares of the stock traded hands, compared to its average volume of 688,222. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The stock has a market cap of $2.36 billion, a price-to-earnings ratio of 8.53, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43. Select Medical Holdings Co. has a 1 year low of $18.02 and a 1 year high of $40.98. The firm's 50 day moving average is $30.38 and its two-hundred day moving average is $33.45.

Select Medical (NYSE:SEM - Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter last year, the firm earned $0.46 earnings per share. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. On average, sell-side analysts anticipate that Select Medical Holdings Co. will post 1.97 EPS for the current year.

Select Medical Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. The ex-dividend date was Wednesday, November 13th. This represents a $0.50 annualized dividend and a dividend yield of 2.74%. Select Medical's dividend payout ratio (DPR) is presently 23.36%.

Analyst Ratings Changes

SEM has been the subject of several research reports. StockNews.com upgraded shares of Select Medical from a "hold" rating to a "buy" rating in a research note on Tuesday, December 3rd. Benchmark downgraded shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, November 25th. Finally, Royal Bank of Canada boosted their price target on Select Medical from $40.00 to $47.00 and gave the stock an "outperform" rating in a research report on Monday, November 4th.

Insiders Place Their Bets

In other Select Medical news, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the transaction, the director now owns 22,000 shares of the company's stock, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the business's stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total value of $99,530.55. Following the sale, the vice president now owns 30,356 shares of the company's stock, valued at approximately $605,602.20. This represents a 14.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 19.14% of the stock is owned by insiders.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.